All In MedTech

FDA Clearance Tracker · P800022

ZYDERM COLLAGEN IMPLANT (ZYDERM CI)

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 19, 2026Latest source record: Jul 22, 1981 (this decision)Source: openFDAMethods & limitations

PMAFirst of its product code

Decided

Jul 22, 1981

Approval withdrawn

Time to decision

446 days

Received May 2, 1980. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P800022
Device name
ZYDERM COLLAGEN IMPLANT (ZYDERM CI)
Applicant
Allergan
Applicant location
Goleta, CA
Received
May 2, 1980
Decided
Jul 22, 1981
Decision
Approval withdrawn
Supplements
45 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code LMH

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code LMH (Implant, dermal, for aesthetic use).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Allergan

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.